Plataforma BIOBADASER III

Registro Español de Acontecimientos Adversos de Terapias Dirigidas en Enfermedades Reumáticas

Biobadaser Fase III

Effectiveness of tocilizumab with and without synthetic disease-modifying antirheumatic drugs in rheumatoid arthritis: results from a European collaborative study. Annals of the rheumatic diseases. 2016;75(7):1336-42.

28/02/2022

Gabay C, Riek M, Hetland ML, Hauge EM, Pavelka K, Tomšic M, et al.

Epub 2015/09/17. doi: 10.1136/annrheumdis-2015-207760. PubMed PMID: 26374404; PubMed Central PMCID: PMCPMC4941183.